Biology of leukotaxis

  • P. A. Ward
  • E. L. Becker
Part of the Reviews of Physiology, Biochemistry and Pharmacology book series (volume 77)


Migration Inhibitor Factor Polymorphonuclear Leukocyte Chemotactic Factor Chemotactic Activity Chemotactic Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adler, J.: Chemotaxis in bacteria. Ann. Rev. Biochera. 44, 391 (1975)Google Scholar
  2. Anton, T., Maderazo, E.G., Ward, P.A.: Leukotactic Dysfunction in Humans with Cancer. In press (1976)Google Scholar
  3. Atherton, A., Born, G.V.R.: Quantitative investigations of the adhesiveness of circulating polymor-phonuclear leukocytes to blood vessel walls. J. Physiol. (Lond.) 22, 447 (1972)Google Scholar
  4. Bandmann, U., Norberg, B., Rydgren, L.: Polymorphonuclear leukocyte chemotaxis in Boyden chambers. Scand. J. Haematol. 13, 305 (1974b)PubMedGoogle Scholar
  5. Bandmann, U., Rydgren, L., Norberg, B.: The difference between random movement and chemotaxis. Exp. Cell Res. 88, 63 (1974a)CrossRefPubMedGoogle Scholar
  6. Basten, A., Beeson, P.B.: Mechanism of eosinophilia II. Role of the lymphocytes. J. Exp. Med. 131, 1288 (1970)PubMedGoogle Scholar
  7. Becker, E.L.: The relationship of the chemotactic behavior of the complement-derived factors C3a, C5a and C357 and a bacterial chemotactic factor to their ability to activate proesterase 1 of rabbit polymorphonuclear leukocytes. J. Exp. Med. 135, 376–387 (1972)CrossRefPubMedGoogle Scholar
  8. Becker, E.L.: Enzyme activation and the mechanism of neutrophil chemotaxis. In Chemotaxis Its Biology and Biochemistry. Sorkin, E. (ed.). Basel: S. Korger 1974, p. 409Google Scholar
  9. Becker, E.L.: Enzyme activation and the mechanism of polymorphonuclear leukocyte chemotaxis. In Cell in Host Resistance. Bellanti, J.A., Dayton, D.H. (eds.). New York: Raven Press, 1975, pps. 1–14Google Scholar
  10. Becker, E.L.: Some inter-relationships among chemotaxis, lysosomal enzyme secretion and phagocytosis. Nobel Symposium. Molecular and Biological Aspects of the Acute Allergic Reaction. In pressGoogle Scholar
  11. Becker, E.L., Davis, A.T., Estenson, R.D., Quie, P.G.: Cytochalasin B IV. Inhibition and stimulation of chemotaxis of rabbit and human polymorphonuclear leukocytes. J. Immunol. 108, 396 (1972)PubMedGoogle Scholar
  12. Becker, E.L., Henson, P.M.: In vitro studies of immunologically induced secretions of mediators from cells and related phenomena. Advanc. Immunol. 17, 93 (1973)Google Scholar
  13. Becker, E.L., Showell, H.J.: The effect of Ca2+ and Mg2+ on the chemotactic responsiveness and spontaneous mobility of rabbit polymorphonuclear leukocytes. Z. Immun. Forsch. 143, 466 (1972)Google Scholar
  14. Becker, E.L., Showell, H.J.: The ability of chemotactic factors to induce lysosomal enzyme release II. The mechanism of the release. J. Immunol. 112, 2055 (1974)PubMedGoogle Scholar
  15. Becker, E.L., Showell, H.J., Henson, P.M., Hsu, L.S.: The ability of chemotactic factors to induce lysosomal enzyme release. 1. The characteristics of the release, the importance of surfaces and the relation of the release to chemotactic responsiveness. J. Immunol. 112, 2047 (1974)PubMedGoogle Scholar
  16. Becker, E.L., Ward, P.A.: Partial biochemical characterization of the activated esterase required in complement dependent chemotaxis of rabbit leukocytes. J. exp. Med. 125, 1021 (1967)CrossRefPubMedGoogle Scholar
  17. Becker, E.L., Ward, P.A.: Enzymatic mechanisms concerned in the complement induced chemotaxis of rabbit polymorphonuclear leukocytes. In: Vth. Internat. Immunopath. Symp. Grabar, P., Miescher, P. (eds.). New York and London: Grune and Stratton, 1967, p. 189Google Scholar
  18. Berenberg, J.L., Ward, P.A.: The chemotactic factor inactivator in normal human serum. J. clin. Invest. 52, 1200 (1973)PubMedGoogle Scholar
  19. Bhisey, A.N., Freed, J.J.: Altered movement of endosomes in colchicine-treated culture macrophages. Exp. Cell Res. 64, 430 (1971)PubMedGoogle Scholar
  20. Bokisch, V.A., Müller-Eberhard, H.J., Cochrane, C.G.: Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum. J. exp. Med. 129, 1109 (1969)CrossRefPubMedGoogle Scholar
  21. Borel, J.F., Staehlein, H.: Effects of cytochalasin B on chemotaxis and immune reactions. Experienta (Basel) 28, 745 (1972)Google Scholar
  22. Boxer, L.A., Hedley-White, E.T., Stossel, T.P.: Neutrophil actin dysfunction and abnormal neutrophil behavior. New Engl. J. Med. 291, 1093 (1974)PubMedGoogle Scholar
  23. Brier, A.M., Snyderman, R., Mergenhager, S.E., Notkins, A.L.: Inflammation and herpes simplex virus: release of a chemotaxis-generating factor from infected cells. Science 170, 1104 (1970)PubMedGoogle Scholar
  24. Brozna, J., Ward, P.A.: Anti-leukotactic properties of tumor cells. J. clin. Invest. 56, 616 (1975)PubMedGoogle Scholar
  25. Bryant, R.E., DePrez, R.M., van Way, M.H., Rogers, D.E.: Studies on leukocyte motility. 1. Effects of alterations in pH, electrolyte concentration and phagocytosis on leukocyte migration, adhesiveness and aggregation. J. exp. Med. 124, 483 (1966)CrossRefPubMedGoogle Scholar
  26. Caner, J.E.Z.: Colchicine inhibition of chemotaxis. Arthr. Rheum. 8, 757 (1965)Google Scholar
  27. Carruthers, B.M.: Leukocyte motility. I. Method of study, normal variation effect of physical alterations in environment and effect of codoacetate. Canad. J. Physiol. Pharmacol. 44, 475 (1966)Google Scholar
  28. Carruthers, B.M.: Leukocyte motility II. Effect of absence of glucose in the medium: effect of presence of deoxyglucose, dinitrophenol, puromycin antimycin D and trypsin on the response to chemotactic substance; effect of segregation of cells from chemotactic substance. Canad. J. Physiol. Pharmacol. 45, 269 (1967)Google Scholar
  29. Chang, C., Houck, J.C.: Demonstration of the chemotactic properties of collagen. Proc. Soc. exp. Biol. (N.Y.) 134, 22 (1970)Google Scholar
  30. Clark, R.A.F., Gallin, J.I., Kaplan, A.P.: The selective eosinophil chemotactic activity of histamine. J. exp. Med. 142, 1462 (1975)CrossRefPubMedGoogle Scholar
  31. Clark, R.A.F., Kimball, H.R.: Defective granulocyte chemotaxis in the Chediak-Higashi syndrome. J. clin. Invest. 51, 649 (1972)Google Scholar
  32. Cochrane, C.G., Müller-Eberhard, H.G.: The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement. J. exp. Med. 127, 371 (1968)PubMedGoogle Scholar
  33. Cohen, S., Ward, P.A.: In vitro and in vivo activity of a lymphocyte and immune complex-dependent chemotactic factor for eosinophils. J. exp. Med. 133, 133–146 (1971)PubMedGoogle Scholar
  34. Cohen, S., Ward, P.A., Yoshida, T., Burek, C.L.: Biological activity of extracts of delayed hypersensitivity skin reaction sites. Cell. Immunol. 9, 363 (1973)CrossRefPubMedGoogle Scholar
  35. Craddock, P.R., Yawata, Y., van Santen, L., Gilberstadt, S., Silvis, S., Jacob, H.S.: Acquired phagocytic dysfunction. A complication of the hypophosphatemia of parental hyperalimentation. New Engl. J. Med. 290, 1403 (1974)PubMedGoogle Scholar
  36. Edelson, P.J., Fudenberg, H.F.: Effect of vinblastine on the chemotactic responsiveness of normal human neutrophils. Infect. Immun. 8, 127 (1973)PubMedGoogle Scholar
  37. Estenson, R.D., Hill, H.R., Quie, P.G., Hogan, N., Goldberg, N.D.: Cyclic GMP and cell movement. Nature (Lond.) 245, 458 (1973)Google Scholar
  38. Fernandez, H., Henson, P., Hugh, T.E.: A single isolation procedure for obtaining both C3a and C5a from activated human serum. J. Immunol. In press (1973)Google Scholar
  39. Gallin, J.I., Rosenthal, A.S.: The regulatory role of divalent cations in human granulocyte chemotaxis: Evidence for an association between calcium exchange and microtubule assembly. J. Cell Biol. 62, 594 (1974)CrossRefPubMedGoogle Scholar
  40. Goetzl, E.J.: Modulation of human neutrophil polymorphonuclear leucocyte migration by human plasma alpha-globulin inhibitors and synthetic esterase inhibitors. Immunol. 29, 163 (1975)Google Scholar
  41. Goetzl, E.J., Austen, K.F.: A neutrophil immobilizing factor derived from human leukocytes. I. Generation and partial characterization. J. exp. Med. 136, 1564 (1972)PubMedGoogle Scholar
  42. Goetzl, E.J., Austen, K.F.: Active site chemotactic factors and the regulation of the human neutrophil chemotactic response. In: Chemotaxis: Its Biology and Biochemistry. Sorkin, E. (ed.). Basel: Karger, 1974a, p. 218Google Scholar
  43. Goetzl, E.J., Austen, K.F.: Stimulation of human neutrophil leukocytic aerobic glucose metabolism by purified chemotactic factors. J. clin. Invest. 53, 591 (1974b)PubMedGoogle Scholar
  44. Goetzl, E.J., Austen, K.F.: Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: Identification as eosinophil chemotactic factor of anaphylaxis. Proc. nat. Acad. Sci. (Wash.) 72, 4123 (1975)Google Scholar
  45. Goetzl, E.J., Wasserman, S.I., Gigli, I., Austen, K.F.: Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid. J. clin. Invest. 53, 813 (1974)PubMedGoogle Scholar
  46. Goldstein, I.M., Hoffstein, S., Gallin, J., Weissmann, G.: Mechanisms of lysosomal enzyme release from human leukocytes: microtubule assembly and membrane fusion induced by a component of complement. Proc. nat. Acad. Sci. (Wash.) 70, 2916 (1973)Google Scholar
  47. Hayashi, H., Yoshinaga, M., Yamamoto, S.: The nature of a mediator of leukocyte chemotaxis in inflammation. In: Chemotaxis: Its Biology and Biochemistry, Sorkin, E. (ed.). Basel: Karger, 1974, p. 296Google Scholar
  48. Hill, H.R., Estenson, R.D., Quie, P.G., Hogan, N.A., Goldberg, N.D.: Modulation of neutrophil chemotactic responses by cyclic 3′,5′-guanosine monophosphate and cyclic 3′,5′ adenosine monophosphate. Metab. 24, 447 (1975)Google Scholar
  49. Hill, J.H., Ward, P.A.: C3 Leukotactic factors produced by a tissue protease. J. exp. Med. 130, 505 (1969)CrossRefPubMedGoogle Scholar
  50. Hill, J.H., Ward, P.A.: The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J. exp. Med. 133, 885 (1971)CrossRefPubMedGoogle Scholar
  51. Hoffstein, S.: Microtubule assembly and secretion in human polymorphonuclear leukocytes. Fed. Proc. 34, 868 (1975)Google Scholar
  52. Hollenberg, M.D., Cuatrecasas, P.: Insulin: Interaction with membrane receptor and relationship to cyclic purine nucleotides and cell growth. Fed. Proc. 34, 1556 (1975)PubMedGoogle Scholar
  53. Hsu, L.S., Becker, E.L.: Chemotactic factor and cytochalasin B induced volume changes in rabbit polymorphonuclear leukocytes. Amer. J. Path. 81, 1 (1975)PubMedGoogle Scholar
  54. Hugli, T.E.: Human anaphylatoxin (C3a) from the third component of complement. J. biol. Chem. 250, 8293 (1975)PubMedGoogle Scholar
  55. Jensen, J.A.: Anaphylatoxins. In: Biological Activities of Complement. Ingram, D. (ed.). Basel: Karger, 1972, p. 136Google Scholar
  56. Kaplan, A.P., Goetzl, E.J., Austen, K.F.: The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivator. J. clin. Invest. 52, 2591 (1973)PubMedGoogle Scholar
  57. Kaplan, A.P., Kay, A.B., Austen, K.F.: A prealbumin activator of prekallikrein. III. Appearance of a chemotactic factor for human neutrophils by the conversion of human prekallikrein to kallikrein. J. exp. Med. 135, 81 (1974)Google Scholar
  58. Kay, A.B.: Studies on eosinophil leucocyte migration. II. Factors specifically chemotactic for eosinophils and neutrophils generated from guinea-pig serum by antigen-antibody complexes. Clin. exp. Immunol. 7, 723 (1970)PubMedGoogle Scholar
  59. Kay, A.B., Stechschulte, D.J., Austen, K.F.: An eosinophil leukocyte chemotactic factor of anaphylaxis. J. exp. Med. 133, 602 (1971)CrossRefPubMedGoogle Scholar
  60. Keller, H.U., Sorkin, E.: Studies on chemotaxis. V. On the chemotactic effect of bacteria. Int. Arch. Allergy 39, 247 (1967)Google Scholar
  61. Keller, H.U., Sorkin, E.: Chemotaxis of leukocytes. Experientia (Basel) 24, 641 (1968)Google Scholar
  62. Konig, W., Czarnetzki, B.M., Lichtenstein, L.M.: Generation and release of eosinophil chemotactic factor (ECF) from human peripheral leukocytes. Fed. Proc. 35, 515 (1976)Google Scholar
  63. Koza, E.P., Wright, T.E., Becker, E.L.: Lysosomal enzyme secretion and volume contraction induced in neutrophils by cytochalasin B, chemotactic factor and A23187. Proc. Soc. exp. Biol. (N.Y.) 34, 173 (1975)Google Scholar
  64. Maderazo, E.G., Ward, P.A., Quintilliani, R.: Defective regulation of chemotaxis in cirrhosis. J. Lab. clin. Med. 85, 621 (1975)PubMedGoogle Scholar
  65. Maderazo, E.G., Ward, P.A., Woronick, C.L., Kubik, J., De Graff, A.C.: Leukotactic dysfunction in sarcoidosis. Ann. intern. Med. 84, 414 (1976a)PubMedGoogle Scholar
  66. Maderazo, E.G., Ward, P.A., Woronick, C.L., Quintilliani, R.: A cell directed inhibitor of leukotaxis in human serum. J. Lab. clin. Med. In press (1976b)Google Scholar
  67. Mowat, A.G., Baum, J.: Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. New Engl. J. Med. 284, 621 (1971)PubMedGoogle Scholar
  68. Müller-Eberhard, H.J.: Complement. Ann. Rev. Biochem. 44, 697 (1975)PubMedGoogle Scholar
  69. Musson, R.A., Becker, E.L.: The effect of chemotactic factors on erythrophagocytosis by human neutrophils. Fed. Proc. 34, 1019 (1975)Google Scholar
  70. Naccache, P., Freer, P.J., Showell, H.J., Becker, E.L., Sha'afi, R.I.: Cation fluxes and chemotaxis. Fed. Proc. 35, 2190 (abst.) (1976)Google Scholar
  71. Oliver, J.M., Zurier, R.B., Berlin, R.D.: Concanavalin A cap formation on polymorphonuclear leukocytes of normal and beige (Chediak-Higashi) mice. Nature (Lond.) 253, 471 (1975)CrossRefGoogle Scholar
  72. Phelps, P., MacCarty, J., Jr.: Crystal induced arthritis. Postgrad. Med. 45, 87 (1969)PubMedGoogle Scholar
  73. Postlethwaite, A., Snyderman, R.: Monocyte leukocyte chemotactic factor in vivo in delayed hypersensitivity. Fed. Proc. 31, 988 (1973)Google Scholar
  74. Ramsey, W.S.: Locomotion of human polymorphonuclear leukocytes. Exp. Cell Res. 72, 489 (1972)CrossRefPubMedGoogle Scholar
  75. Ramsey, W., Harris, A.: Leukocyte locomotion and its inhibition by antimitotic drugs. Exp. Cell Res. 82, 262 (1973)CrossRefPubMedGoogle Scholar
  76. Ramsey, W.S.: In: Chemotaxis: Its Biology and Biochemistry. Sorkin, E. (ed.). Basel: Karger, 1974 a, p. 179Google Scholar
  77. Ramsey, W.: Retraction fibers and leukocyte chemotaxis. Exp. Cell Res. 86, 184 (1974b)CrossRefPubMedGoogle Scholar
  78. Rivkin, I., Becker, E.L.: Effect of exogenous cyclic AMP and other adenine nucleotides on neutrophil chemotaxis and motility. Int. Arch. Allergy 50, 95 (1975)Google Scholar
  79. Rivkin, I., Rosenblatt, J., Becker, E.L.: The role of cyclic AMP in the chemotactic responsiveness and spontaneous motility of rabbit peritoneal neutrophils. The inhibition of neutrophil movement and elevation of cyclic AMP levels by catecholamines, prostaglandins, theophylline and cholera toxin. J. Immunol. 115, 1114 (1975)Google Scholar
  80. Sandler, J.A., Gallin, J.I., Vaughn, E.: Effects of serotonin, carbamylcholine and ascorbic acid on leukocyte cyclic GMP and chemotaxis. J. cell. Biol. 67, 480 (1975)CrossRefPubMedGoogle Scholar
  81. Schiffmann, E., Showell, H., Corcoran, B., Ward, P.A., Smith, E., Becker, E.L.: The isolation and partial characterization of neutrophil chemotactic factor from Escherichia coli. J. Immunol. 114, 1831 (1975a)PubMedGoogle Scholar
  82. Schiffmann, E.A., Corcoran, B.A., Wall, S.M.: Formylmethionyl peptides as chemoattractants for leukocytes. Proc. nat. Acad. Sci. (Wash.) 70, 2916 (1975b)Google Scholar
  83. Shin, H.W., Snyderman, R., Friedman, E., Mellors, A., Mayer, M.M.: Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement. Science 122, 361 (1968)Google Scholar
  84. Showell, H.J., Becker, E.L.: The effects of external K+ and Na+ on the chemotaxis of rabbit peritoneal neutrophils. J. Immunol. 116, 99 (1976)PubMedGoogle Scholar
  85. Showell, H.J., Freer, R.J., Zigmond, S.H., Schiffman, E., Aswanikumar, S., Corcoran, B., Becker, E.L.: The structure activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal enzyme secretion for neutrophils. J. exp. Med. In press 1976Google Scholar
  86. Smith, C.W., Hollers, J.C., Bing, D.H., Patrick, R.A.: Effects of human CI inhibitor on complementmediated human leukocyte chemotaxis. J. Immunol. 114, 216 (1975)PubMedGoogle Scholar
  87. Snyderman, R., Phillips, J., Mergenhagen, S.E.: Polymorphonuclear leukocyte chemotactic activity in rabbit serum and guinea pig serum treated with immune complexes: Evidence for C5a as the major chemotactic factor. Infect. Immunol. 1, 521 (1970)Google Scholar
  88. Snyderman, R., Phillips, J., Mergenhagen, S.E.: Biological activity of complement in vivo. Role of C5 in the accumulation of polymorphonuclear leukocytes in inflammatory exudates. J. exp. Med. 134, 1131 (1971)CrossRefPubMedGoogle Scholar
  89. Stecher, V.J., Sorkin, E.: The chemotactic activity of fibrin lysis products. Int. Arch. Allergy 43, 879 (1972)PubMedGoogle Scholar
  90. Stossel, T.P.: Phagocytosis: Recognition and ingestion. Semin. Hemat. 12, 83 (1975)PubMedGoogle Scholar
  91. Temple, T.R., Snyderman, R., Jordan, H.V., Mergenhagen, S.E.: Factors from saliva and oral bacteria, chemotactic for polymorphonuclear leukocytes: their possible role in gingivalinflammation. J. Periodont. 41, 71 (1970)Google Scholar
  92. Till, G., Ward, P.A.: Two distinct chemotactic factor inactivators in human serum. J. Immunol. 114, 843 (1975)PubMedGoogle Scholar
  93. Torisu, M., Yoshida, T., Ward, P.A., Cohen, S.: Lymphocyte-derived eosinophil chemotactic factor. I. Studies on the mechanism of activation of the precursor substance by immune complexes. J. Immunol. 111, 1450–1458 (1973)PubMedGoogle Scholar
  94. Tse, R.L., Phelps, P., Urban, D.: Polymorphonuclear leukocyte motility in vitro. VI. Effect of purine and pyrimidine analogues: Possible role of cyclic AMP. J. Lab. clin. Med. 80, 265 (1972)Google Scholar
  95. Tsung, P.K., Kegeles, S., Becker, E.L.: Isolation of an acetyl DL phenylalanine β-naphthyl esterase from rabbit peritoneal polymorphonuclear leukocytes. Biochim. biophys. Acta 403, 98 (1975a)PubMedGoogle Scholar
  96. Tsung, P., Sakamoto, T., Weissmann, G.: Protein kinase and phosphatase from human polymorphonuclear leukocytes. Biochem. J. 145, 437 (1975b)PubMedGoogle Scholar
  97. Turner, S.R., Campbell, J.A., Lynn, W.S.: Polymorphonuclear leukocyte chemotaxis toward oxidized lipid components of cell membranes. J. exp. Med. 141, 1437 (1975)CrossRefPubMedGoogle Scholar
  98. Vallota, E., Müller-Eberhard, H.J.: Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator. J. exp. Med. 137, 1109 (1973)CrossRefPubMedGoogle Scholar
  99. Vogt, W., Lufft, E., Schmidt, G.: Studies of the relation between the fifth component and complement and anaphylatoxinogen. Europ. J. Immunol. 1, 141 (1971)Google Scholar
  100. Ward, P.A.: A plasmin-split fragment of C's as a new chemotactic factor. J. exp. Med. 126, 189–206 (1967)CrossRefPubMedGoogle Scholar
  101. Ward, P.A.: Chemotaxis of polymorphonuclear leukocytes. Biochem. Pharmacol. spec. Suppl. 99 (1968)Google Scholar
  102. Ward, P.A.: The heterogeneity of chemotactic factors for neutrophils generated from the complement system. In: Cellular and Humoral Mechanisms in Anaphylaxis and Allergy. Movat, H.Z. (ed.). Basel and New York: Karger, 1969, p. 279Google Scholar
  103. Ward, P.A.: Leukotactic factors in health and disease. Amer. J. Path. 64. 521 (1971)PubMedGoogle Scholar
  104. Ward, P.A.: Complement derived chemotactic factors and their interactions with neutrophilic granulocytes. In “Biological Activities of Complement”, Fifth International Symposium of the Canadian Society of Immunology, edited by D. Ingram, pg. 108–116 (1972)Google Scholar
  105. Ward, P.A.: Leukotaxis and leukotactic disorders. Amer. J. Path. 77, 519–538 (1974)Google Scholar
  106. Ward, P.A., Becker, E.L.: The deactivation of rabbit neutrophils by chemotactic factor and the nature of the activatable esterase. J. exp. Med. 127, 693 (1968)CrossRefPubMedGoogle Scholar
  107. Ward, P.A., Berenberg, J.L.: Defective regulation of inflammatory mediators in Hodgkin's disease. Supernormal levels of chemotactic factor inactivator. New Engl. J. Med. 290, 76–80 (1974)PubMedGoogle Scholar
  108. Ward, P.A., Chapitis, J., Conroy, M.C., Lepow, I.H.: Generation by bacterial proteinases of leukotactic factors from human serum and C3 and C5. J. Immunol. 110, 1003–1009 (1973)Google Scholar
  109. Ward, P.A., Cochrane, C.G.: Bound complement and immunologic vasculitis. J. exp. Med. 121, 215 (1965)CrossRefPubMedGoogle Scholar
  110. Ward, P.A., Data, R., Till, G.: Regulatory control of complement derived chemotactic and anaphylatoxin mediators. In: Progress in Immunology II. Brest, L., Holborow, J. (eds.). Amsterdam: North-Holland, 1974, Vol. I, pp. 209–215Google Scholar
  111. Ward, P.A., Dvorak, H.F., Cohen, S., Yoshida, T., Data, R., Selvaggio, S.: Chemotaxis of basophils by lymphocyte-dependent and lymphocyte-independent mechanisms. J.Immunol. 114, 1523–1531 (1975)PubMedGoogle Scholar
  112. Ward, P.A., Goralnick, S., Bullock, W.E.: Defective leukotaxis in patients with lepromatous leprosy. J. Lab. clin. Med. 87, 1025 (1976)PubMedGoogle Scholar
  113. Ward, P.A., Hill, J.H.: C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils. J. Immunol. 104, 535 (1970)PubMedGoogle Scholar
  114. Ward, P.A., Hill, J.H.: Biological role of complement products. Complement-derived leukotactic activity extractable from lesions of immunologic vasculitis. J. Immunol. 108, 1137 (1972)PubMedGoogle Scholar
  115. Ward, P.A., Lepow, I.H., Newman, L.J.: Bacterial factors chemotactic for polymorphonuclear leukocytes. Amer. J. Path. 52, 725 (1968)PubMedGoogle Scholar
  116. Ward, P.A., Newman, L.J.: A neutrophil chemotactic factor from human C5. J. Immunol. 102, 93–99 (1969)PubMedGoogle Scholar
  117. Ward, P.A., Ozols, J.: The protease activity of the chemotactic factor inactivator. J. clin. Invest. 58, 123 (1976)PubMedGoogle Scholar
  118. Ward, P.A., Remold, H.G., David, J.R.: A leukotactic factor produced by sensitized lymphocytes. Science 163, 1079–1081 (1969)PubMedGoogle Scholar
  119. Ward, P.A., Rocklin, R.: Regulation of MIF by a factor in human serum. J. Immunol. 115, 309–311 (1975)PubMedGoogle Scholar
  120. Ward, P.A., Volkman, A.: The elaboration of leukotactic mediators during the interaction between parental-type lymphocytes and F1 hybrid cells. J. Immunol. 115, 1394–1399 (1975)PubMedGoogle Scholar
  121. Ward, P.A., Zvaifler, N.J.: Complement derived leukotactic factors in inflammatory synovial fluids of humans. J. clin. Invest. 50, 606 (1971)PubMedGoogle Scholar
  122. Wasserman, S.I., Goetzl, E.J., Ellman, L., Austen, K.F.: Tumor-associated eosinophilotactic factor. New Engl. J. Med. 290, 420 (1974)PubMedGoogle Scholar
  123. Weiner, S.L., Lendair, S., Rogers, B., Urivetzsky, M., Meilwan, E.: Non-immune chemotaxis in vivo: inhibition by complement depletion with cobra factor. Amer. J. Path. 73, 807 (1973)Google Scholar
  124. Wilkinson, P.C.: Chemotaxis and Inflammation. Edinburgh: Churchill Livingstone, 1974a, p. 94Google Scholar
  125. Wilkinson, P.C.: Surface and cell membrane activities of leukocytic chemotactic factors. Nature (Lond.) 251, 58 (1974b)CrossRefGoogle Scholar
  126. Wilkinson, P.C.: Leukocyte locomotion and chemotaxis. Exp. Cell Res. 93, 420 (1975a)CrossRefPubMedGoogle Scholar
  127. Wilkinson, P.C.: Inhibition of leukocyte motion and chemotaxis by lipid-specific-bacterial toxins. Nature (Lond.) 255, 485 (1975b)CrossRefGoogle Scholar
  128. Wissler, J.H., Stecher, V., Sorkin, E.: Chemistry and biology of the anaphylatoxin related peptide system. III. Evaluation of leukocyte activity as the property of a new peptide system with classical anaphylatoxin and cocytalaxin components. Europ. J. Immunol. 2, 90 (1972)Google Scholar
  129. Zigmond, S.H.: Mechanisms of sensing chemical gradients by polymorphonuclear leukocytes. Nature (Lond.) 249, 450 (1974)CrossRefGoogle Scholar
  130. Zigmond, S.H., Hirsch, J.G.: Effects of cytochalasin B on polymorphonuclear leukocyte locomotion, phagocytosis and glycolysis. Exp. Cell Res. 73, 383 (1972)CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 1977

Authors and Affiliations

  • P. A. Ward
  • E. L. Becker

There are no affiliations available

Personalised recommendations